{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:57:35Z","timestamp":1783105055029,"version":"3.54.6"},"reference-count":66,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Chemotherapy-induced alopecia (CIA) significantly impacts patients'\nemotional and psychological well-being and treatment regimen. Phenylephrine, a topical vasoconstrictor,\ncan potentially reduce hair loss by limiting chemotherapy drug delivery to hair follicles.\nHowever, effective delivery of Phenylephrine through the skin remains challenging. This\nstudy investigates lipid vesicles as delivery vehicles to enhance Phenylephrine's skin permeation\nand sustained release due to their biocompatibility and encapsulation capabilities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to formulate and compare different lipid vesicles of Phenylephrine\nHCl for enhanced permeation through the skin for deep dermal delivery with sustained release of\nthe drug so as to achieve local vasoconstriction.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Phenylephrine-loaded ethosomes, invasomes, and transfersomes were prepared and\ncharacterized for particle size (PS), polydispersity index (PDI), and entrapment efficiency\n(EE %). These lipid vesicles were incorporated into hydrogels to facilitate sustained drug release\nto deep dermal layers where they could target local vasculature and cause vasoconstriction. The\nprepared vesicular gels were evaluated for various permeation parameters.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The entrapment efficiencies of the developed vesicles ranged from 49.51 \u00b1 3.25% to\n69.09 \u00b1 2.32%, with vesicle sizes ranging from 162.5 \u00b1 5.21 nm to 321.32 \u00b1 3.75 nm. Statistical\nanalysis revealed significantly higher flux values (Jss, \u03bcg\/cm2 h) of 0.6251, 0.6314, and 0.4075\nfor invasomal gel, ethosomal gel, and transfersomal gel, respectively, compared to plain gel\n(0.1254) (p &lt; 0.005). The enhancement factors were 4.9848, 5.0350, and 3.2496 for invasomal\ngel, ethosomal gel, and transfersomal gel, respectively, indicating superior permeation abilities\nof ethosomal and invasomal formulations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results demonstrate that ethosomal and invasomal formulations were efficient\nin delivering the drug to deep dermal layers of skin in a sustained manner. These findings suggest\nthat these Lipidic vesicles would be able to target the local vasoconstrictor to vasculature,\ncausing reduced hair loss by limiting chemotherapy drug delivery to hair follicles and managing\nchemotherapy-induced alopecia.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010336809240815050316","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T07:21:53Z","timestamp":1729495313000},"page":"465-475","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative Study on Enhanced Skin Permeation Efficiency of Phenylephrine via Novel Lipid Vesicles: A Promising Approach in Preventing Chemotherapy-induced Alopecia Management"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9586-5861","authenticated-orcid":true,"given":"Ravi","family":"Shankar","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, 281406, (UP), India"},{"name":"TRC Mahavidyalaya, Dept. of\nPharmacy, Satrikh, Barabanki, (UP), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2042-1243","authenticated-orcid":true,"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhat Kumar","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, 281406, (UP), India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cncr.10630","volume":"95","author":"Carelle N.","year":"2002","unstructured":"Carelle N.; Piotto E.; Bellanger A.; Germanaud J.; Thuillier A.; Khayat D.; Changing patient perceptions of the side effects of cancer chemotherapy. Cancer  2002,95(1),155-163","journal-title":"Cancer"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jaad.2010.06.051","volume":"65","author":"Balagula Y.","year":"2011","unstructured":"Balagula Y.; Rosen S.T.; Lacouture M.E.; The emergence of supportive oncodermatology: The study of dermatologic adverse events to cancer therapies. J Am Acad Dermatol  2011,65(3),624-635","journal-title":"J Am Acad Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s11095-006-9105-3","volume":"23","author":"Wang J.","year":"2006","unstructured":"Wang J.; Lu Z.; Au J.L.S.; Protection against chemotherapy-induced alopecia. Pharm Res  2006,23(11),2505-2514","journal-title":"Pharm Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.lungcan.2010.07.004","volume":"72","author":"Bernard M.","year":"2011","unstructured":"Bernard M.; Brignone M.; Adehossi A.; Pefoura S.; Briquet C.; Chouaid C.; Tilleul P.; Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay study. Lung Cancer  2011,72(1),114-118","journal-title":"Lung Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1523-5394.2001.96007.pp.x","volume":"9","author":"McGarvey E.L.","year":"2001","unstructured":"McGarvey E.L.; Baum L.D.; Pinkerton R.C.; Rogers L.M.; Psychological sequelae and alopecia among women with cancer. Cancer Pract  2001,9(6),283-289","journal-title":"Cancer Pract"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e2020074","DOI":"10.5826\/dpc.1003a74","volume":"10","author":"Rossi A.","year":"2020","unstructured":"Rossi A.; Caro G.; Fortuna M.C.; Pigliacelli F.; D\u2019Arino A.; Carlesimo M.; Prevention and treatment of chemotherapy-induced alopecia. Dermatol Pract Concept  2020,10(3),e2020074","journal-title":"Dermatol Pract Concept"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/ijd.15812","volume":"60","author":"Santos T.S.","year":"2021","unstructured":"Santos T.S.; Hernand\u00e9z Galvis K.; Va\u00f1\u00f3 Galv\u00e1n S.; Saceda-Corralo D.; Post\u2010chemotherapy alopecia: What the dermatologist needs to know. Int J Dermatol  2021,60(11),1313-1317","journal-title":"Int J Dermatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","volume":"155","author":"Freites-Martinez A.","year":"2019","unstructured":"Freites-Martinez A.; Chan D.; Sibaud V.; Shapiro J.; Fabbrocini G.; Tosti A.; Cho J.; Goldfarb S.; Modi S.; Gajria D.; Norton L.; Paus R.; Cigler T.; Lacouture M.E.; Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia. JAMA Dermatol  2019,155(6),724-728","journal-title":"JAMA Dermatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","volume":"24","author":"Kang D.","year":"2019","unstructured":"Kang D.; Kim I.R.; Choi E.K.; Im Y.H.; Park Y.H.; Ahn J.S.; Lee J.E.; Nam S.J.; Lee H.K.; Park J.H.; Lee D.Y.; Lacouture M.E.; Guallar E.; Cho J.; Permanent chemotherapy-induced alopecia in patients with breast cancer: A 3-year prospective cohort study. Oncologist  2019,24(3),414-420","journal-title":"Oncologist"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e13395","DOI":"10.1111\/ecc.13395","volume":"30","author":"Chan J.","year":"2021","unstructured":"Chan J.; Adderley H.; Alameddine M.; Armstrong A.; Arundell D.; Fox R.; Harries M.; Lim J.; Salih Z.; Tetlow C.; Wong H.; Thorp N.; Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres. Eur J Cancer Care (Engl)  2021,30(3),e13395","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref=11","first-page":"5","volume":"15","author":"Tr\u00fceb R.M.","year":"2010","unstructured":"Tr\u00fceb R.M.; Chemotherapy-induced hair loss. Skin Therapy Lett  2010,15(7),5-7","journal-title":"Skin Therapy Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","volume":"14","author":"Paus R.","year":"2013","unstructured":"Paus R.; Haslam I.S.; Sharov A.A.; Botchkarev V.A.; Pathobiology of chemotherapy-induced hair loss. Lancet Oncol  2013,14(2),e50-e59","journal-title":"Lancet Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1586\/edm.10.76","volume":"6","author":"Breed W.P.M.","year":"2011","unstructured":"Breed W.P.M.; van den Hurk C.J.G.; Peerbooms M.; Presentation, impact and prevention of chemotherapy-induced hair loss: Scalp cooling potentials and limitations. Expert Rev Dermatol  2011,6(1),109-125","journal-title":"Expert Rev Dermatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1634\/theoncologist.2012-0332","volume":"18","author":"Komen M.M.C.","year":"2013","unstructured":"Komen M.M.C.; Smorenburg C.H.; Hurk C.J.G.; Nortier J.W.R.; Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist  2013,18(7),885-891","journal-title":"Oncologist"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0959-8049(96)00374-7","volume":"33","author":"Lemenager M.","year":"1997","unstructured":"Lemenager M.; Lecomte S.; Bonneterre M.E.; Bessa E.; Dauba J.; Bonneterre J.; Effectiveness of cold cap in the prevention of docetaxel-induced alopecia. Eur J Cancer  1997,33(2),297-300","journal-title":"Eur J Cancer"},{"key":"ref=16","first-page":"231","volume":"37","author":"Hillen H.F.","year":"1990","unstructured":"Hillen H.F.; Breed W.P.; Botman C.J.; Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia. Neth J Med  1990,37(5-6),231-235","journal-title":"Neth J Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/hex.13679","volume":"26","author":"Delgado Rodr\u00edguez J.","year":"2023","unstructured":"Delgado Rodr\u00edguez J.; Ramos-Garc\u00eda V.; Infante-Ventura D.; Suarez-Herrera J.C.; Rueda-Dom\u00ednguez A.; Serrano-Aguilar P.; del Mar Trujillo-Mart\u00edn M.; Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy\u2010induced alopecia: A systematic review. Health Expect  2023,26(2),567-578","journal-title":"Health Expect"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"6943","DOI":"10.1007\/s00520-021-06188-8","volume":"29","author":"Wang S.","year":"2021","unstructured":"Wang S.; Yang T.; Shen A.; Qiang W.; Zhao Z.; Zhang F.; The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: A systematic review and meta-analysis. Support Care Cancer  2021,29(11),6943-6956","journal-title":"Support Care Cancer"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ijc.28961","volume":"136","author":"Soref C.M.","year":"2015","unstructured":"Soref C.M.; Fahl W.E.; A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor. Int J Cancer  2015,136(1),195-203","journal-title":"Int J Cancer"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/jid.2013.113","volume":"133","author":"Rathman-Josserand M.","year":"2013","unstructured":"Rathman-Josserand M.; Genty G.; Lecardonnel J.; Chabane S.; Cousson A.; Fran\u00e7ois Michelet J.; Bernard B.A.; Human hair follicle stem\/progenitor cells express hypoxia markers. J Invest Dermatol  2013,133(8),2094-2097","journal-title":"J Invest Dermatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","volume":"65","author":"Touitou E.","year":"2000","unstructured":"Touitou E.; Dayan N.; Bergelson L.; Godin B.; Eliaz M.; Ethosomes \u2014 Novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J Control Release  2000,65(3),403-418","journal-title":"J Control Release"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.12.005","volume":"332","author":"Elsayed M.M.A.","year":"2007","unstructured":"Elsayed M.M.A.; Abdallah O.Y.; Naggar V.F.; Khalafallah N.M.; Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. Int J Pharm  b2007,332(1-2),1-16","journal-title":"Int J Pharm"},{"key":"ref=23","author":"Dragicevic N.","year":"2018","unstructured":"Dragicevic N.; Maibach H.I.;  Liposomes in transdermal and topical drug delivery  2018","journal-title":"Liposomes in transdermal and topical drug delivery"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jconrel.2019.01.021","volume":"295","author":"Moen E.K.","year":"2019","unstructured":"Moen E.K.; Yang S.; Anderson J.L.; Arndt-Jovin D.J.; Overcoming the stratum corneum barrier: A study of permeation enhancers in liposomal delivery systems. J Control Release  2019,295,73-84","journal-title":"J Control Release"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"8578","DOI":"10.1021\/acsomega.7b01518","volume":"2","author":"J\u00f8raholmen M.W.","year":"2017","unstructured":"J\u00f8raholmen M.W.; \u0160kalko-Basnet N.; Acharya G.; Basnet P.; Liposomal delivery system enhancing dermal and transdermal drug delivery. ACS Omega  2017,2(12),8578-8589","journal-title":"ACS Omega"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejps.2008.05.002","volume":"34","author":"El Maghraby G.M.","year":"2008","unstructured":"El Maghraby G.M.; Barry B.W.; Williams A.C.; Liposomes and skin: From drug delivery to model membranes. Eur J Pharm Sci  2008,34(4-5),203-222","journal-title":"Eur J Pharm Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0005-2736(92)90154-E","volume":"1104","author":"Cevc G.","year":"1992","unstructured":"Cevc G.; Blume G.; Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta Biomembr  1992,1104(1),226-232","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0005-2736(01)00369-8","volume":"1514","author":"Cevc G.","year":"2001","unstructured":"Cevc G.; Blume G.; New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochim Biophys Acta Biomembr  2001,1514(2),191-205","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijpharm.2010.05.046","volume":"395","author":"Maestrelli F.","year":"2010","unstructured":"Maestrelli F.; Gonz\u00e1lez-Rodr\u00edguez M.L.; Rabasco A.M.; Ghelardini C.; Mura P.; New \u201cdrug-in cyclodextrin-in deformable liposomes\u201d formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm  2010,395(1-2),222-231","journal-title":"Int J Pharm"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/S0142-9612(00)00063-6","volume":"21","author":"Dayan N.","year":"2000","unstructured":"Dayan N.; Touitou E.; Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs. liposomes. Biomaterials  2000,21(18),1879-1885","journal-title":"Biomaterials"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i1.20","volume":"20","author":"Godin B.","year":"2003","unstructured":"Godin B.; Touitou E.; Ethosomes: New prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst  2003,20(1),63-102","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijpharm.2016.03.030","volume":"505","author":"Kamran M.","year":"2016","unstructured":"Kamran M.; Ahad A.; Aqil M.; Imam S.S.; Sultana Y.; Ali A.; Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment. Int J Pharm  2016,505(1-2),147-158","journal-title":"Int J Pharm"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"118657","DOI":"10.1016\/j.ijpharm.2019.118657","volume":"570","author":"Ahmed O.A.A.","year":"2019","unstructured":"Ahmed O.A.A.; Badr-Eldin S.M.; Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation. Int J Pharm  2019,570,118657","journal-title":"Int J Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1208\/s12249-018-1025-0","volume":"19","author":"El-Nabarawi M.A.","year":"2018","unstructured":"El-Nabarawi M.A.; Shamma R.N.; Farouk F.; Nasralla S.M.; Dapsone-loaded invasomes as a potential treatment of acne: Preparation, characterization, and in vivo skin deposition assay. AAPS PharmSciTech  2018,19(5),2174-2184","journal-title":"AAPS PharmSciTech"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ajps.2013.09.005.","author":"Lin H.","year":"2013","unstructured":"Lin H.; Yu C.; Lei W.; Zhou X.; Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo . Asian. Asian Jour Pharm Sci  2013,336-345","journal-title":"Asian Jour Pharm Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijpharm.2015.03.020","volume":"485","author":"Abdelbary A.A.","year":"2015","unstructured":"Abdelbary A.A.; AbouGhaly M.H.H.; Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box\u2013Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm  2015,485(1-2),235-243","journal-title":"Int J Pharm"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jbm.b.10046","volume":"66B","author":"Zweers M.L.T.","year":"2003","unstructured":"Zweers M.L.T.; Grijpma D.W.; Engbers G.H.M.; Feijen J.; The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size. J Biomed Mater Res B Appl Biomater  2003,66B(2),559-566","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/j.1349-7006.1990.tb03345.x","volume":"81","author":"Ichino T.","year":"1990","unstructured":"Ichino T.; Yotsuyanagi T.; Mizuno I.; Akamo Y.; Yamamoto T.; Saito T.; Kurahashi S.; Tanimoto N.; Yura J.; Antitumor effect of liposome-entrapped adriamycin administered via the portal vein. Jpn J Cancer Res  1990,81(10),1052-1056","journal-title":"Jpn J Cancer Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/10837450802409438","volume":"14","author":"Patel N.A.","year":"2009","unstructured":"Patel N.A.; Patel N.J.; Patel R.P.; Formulation and evaluation of curcumin gel for topical application. Pharm Dev Technol  2009,14(1),83-92","journal-title":"Pharm Dev Technol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-5173(01)00637-8","volume":"219","author":"Paveli\u0107 \u017d.","year":"2001","unstructured":"Paveli\u0107 \u017d.; \u0160kalko-Basnet N.; Schubert R.; Liposomal gels for vaginal drug delivery. Int J Pharm  2001,219(1-2),139-149","journal-title":"Int J Pharm"},{"key":"ref=41","first-page":"43","volume":"2","author":"Kaur L.P.","year":"2010","unstructured":"Kaur L.P.; Garg R.; Gupta G.D.; Development and evaluation of topical gel of minoxidil from different polymer bases in application of alopecia. Int J Pharm Pharm Sci  2010,2,43-47","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijpharm.2008.08.021.","volume":"365","author":"Bachhav YG.","year":"2009","unstructured":"Bachhav YG.; Patravale VB.; Microemulsion based vaginal gel of fluconazole: Formulation, in vitro and in vivo evaluation. Int J Pharm  2009,365(1-2),175-9","journal-title":"Int J Pharm"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijbiomac.2013.01.015","volume":"55","author":"Chaudhary H.","year":"2013","unstructured":"Chaudhary H.; Rohilla A.; Rathee P.; Kumar V.; Optimization and formulation design of carbopol loaded Piroxicam gel using novel penetration enhancers. Int J Biol Macromol  2013,55,246-253","journal-title":"Int J Biol Macromol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.36347\/sajp.2022.v11i07.001","volume":"11","author":"Verma H.","year":"2022","unstructured":"Verma H.; Pal D.P.; Joshi D.; Formulation, development and evaluation of invasomes loaded gel for fungal treatment. Sch Acad J Pharm  2022,11(7),105-108","journal-title":"Sch Acad J Pharm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.onano.2022.100058","volume":"7","author":"Kumar B.","year":"2022","unstructured":"Kumar B.; Sahoo P.K.; Manchanda S.; Formulation, characterization and ex vivo study of curcumin nano-invasomal gel for enhanced transdermal delivery. OpenNano  2022,7,100058","journal-title":"OpenNano"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"582","DOI":"10.4103\/0250-474X.78524","volume":"72","author":"Ramteke S.","year":"2010","unstructured":"Ramteke S.; Barupal A.K.; Gupta V.; Preparation and characterization of ethosomes for topical delivery of aceclofenac. Indian J Pharm Sci  2010,72(5),582-586","journal-title":"Indian J Pharm Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2139\/ssrn.3774625.","volume":"44","author":"Maurya Sheo Datta.","year":"2010","unstructured":"Maurya Sheo Datta.; Prajapati Sunil Kumar.; Gupta Anish Kumar.; Saxena Gyanendra Kumar.; Dhakar Ram Chand.; Formulation development and evaluation of ethosome of stavudine. Indian J Pharm Educ Res  2010,44(1),102-108","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jconrel.2005.04.007","volume":"106","author":"Paolino D.","year":"2005","unstructured":"Paolino D.; Lucania G.; Mardente D.; Alhaique F.; Fresta M.; Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release  2005,106(1-2),99-110","journal-title":"J Control Release"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.21776\/ub.pji.2020.005.02.7","volume":"5","author":"Nurmahliati H.","year":"2020","unstructured":"Nurmahliati H.; Widodo F.; Puspita O.; Effect of soy lecithin and sodium cholate concentration on characterization pterostilbene transfersomes. Indones J Pharm  2020,5(2),109-115","journal-title":"Indones J Pharm"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.22487\/j24428744.2023.v9.i1.16085","volume":"9","author":"Zubaydah W. O. S.","year":"2023","unstructured":"Zubaydah W. O. S.; Andriani R.; Suryani S.; Indalifiani .A; Jannah S.R.N.; Hidayati D.; Optimization of soya phosphatidylcholine and tween 80 as a preparation of diclofenac sodium transfersome vesicles using design-expert. Galenika J Pharm  2023,9(1),84-98","journal-title":"Galenika J Pharm"},{"key":"ref=51","first-page":"35","volume":"3","author":"Jadupati M.","year":"2012","unstructured":"Jadupati M.; Kumar N.A.; Transferosome: An opportunistic carrier for transdermal drug delivery system. Int Res J Pharm  2012,3,35-38","journal-title":"Int Res J Pharm"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2007.08.005","volume":"123","author":"Dubey V.","year":"2007","unstructured":"Dubey V.; Mishra D.; Dutta T.; Nahar M.; Saraf D.K.; Jain N.K.; Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release  2007,123(2),148-154","journal-title":"J Control Release"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jconrel.2018.06.029","volume":"285","author":"Kim B.P.G.","year":"2018","unstructured":"Kim B.P.G.; Mendes L.P.; Lu M.J.T.Y.; Optimizing vesicle size for effective skin penetration and drug delivery. J Control Release  2018,285,13-23","journal-title":"J Control Release"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejpb.2018.07.012","volume":"130","author":"Tariq M.A.S.","year":"2018","unstructured":"Tariq M.A.S.; Singh A.G.; Smith A.H.; Lopez C.M.; Nanoparticle size and skin penetration: The role of vesicle size in dermal drug delivery. Eur J Pharm Biopharm  2018,130,132-145","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jconrel.2019.01.002","volume":"300","author":"Park J.H.","year":"2019","unstructured":"Park J.H.; Jang L.B.; Lee M.K.; The role of vesicle size in dermal delivery of therapeutics: comparative analysis of different lipid vesicles. J Control Release  2019,300,118-130","journal-title":"J Control Release"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.20961\/jpscr.v2i01.5238","volume":"2","author":"Saryanti D.","year":"2017","unstructured":"Saryanti D.; Zulfa I.N.; Optimization carbopol and glycerol as basis of hand gel antiseptics extract ethanol ceremai leaf (Phyllantus acidus (L.) Skeels) with simplex lattice design. JPSCR  2017,2(1),35-43","journal-title":"JPSCR"},{"key":"ref=57","author":"Rowe R.C.","year":"2009","unstructured":"Rowe R.C.; Sheskey P.J.; Quinn M.E.;  Handbook of Pharmaceutical Excipients  2009","journal-title":"Handbook of Pharmaceutical Excipients"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/gels9080645","volume":"9","author":"Kurniawansyah I.S.","year":"2023","unstructured":"Kurniawansyah I.S.; Rusdiana T.; Sopyan I.; Desy Arya I.F.; Wahab H.A.; Nurzanah D.; Comparative study of in situ gel formulation based on the physico-chemical aspect: Systematic review. Gels  2023,9(8),645","journal-title":"Gels"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/0250-474X.106066","volume":"74","author":"Shinde U.","year":"2012","unstructured":"Shinde U.; Pokharkar S.; Modani S.; Design and evaluation of microemulsion gel system of nadifloxacin. Indian J Pharm Sci  2012,74(3),237-247","journal-title":"Indian J Pharm Sci"},{"key":"ref=60","author":"Lohani A.","year":"2011","unstructured":"Lohani A.; Formulation, development and evaluation of ciprofloxacin hydrochloride soft gel for oral administration.  2011"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1211\/jpp.62.04.0004","volume":"62","author":"Carvalho F.C.","year":"2010","unstructured":"Carvalho F.C.; Barbi M.S.; Sarmento V.H.V.; Chiavacci L.A.; Netto F.M.; Gremi\u00e3o M.P.D.; Surfactant systems for nasal zidovudine delivery: structural, rheological and mucoadhesive properties. J Pharm Pharmacol  2010,62(4),430-439","journal-title":"J Pharm Pharmacol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ajps.2013.09.005","volume":"8","author":"Lei W.","year":"2013","unstructured":"Lei W.; Yu C.; Lin H.; Zhou X.; Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo . Asian Jour Pharm Sci  2013,8(6),336-345","journal-title":"Asian Jour Pharm Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12272-012-0112-0","volume":"35","author":"Zhang J.P.","year":"2012","unstructured":"Zhang J.P.; Wei Y.H.; Zhou Y.; Li Y.Q.; Wu X.A.; Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: A comparative study. Arch Pharm Res  2012,35(1),109-117","journal-title":"Arch Pharm Res"},{"key":"ref=64","first-page":"133","volume":"62","author":"Elsayed M.M.","year":"2007","unstructured":"Elsayed M.M.; Abdallah O.Y.; Naggar V.F.; Khalafallah N.M.; Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie  2007,62(2),133-137","journal-title":"Pharmazie"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3109\/03639045.2010.532219","volume":"37","author":"Ahad A.","year":"2011","unstructured":"Ahad A.; Aqil M.; Kohli K.; Sultana Y.; Mujeeb M.; Ali A.; Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug Dev Ind Pharm  2011,37(5),583-596","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/0975-8453.135837","volume":"4","author":"Lakshmi P.K.","year":"2013","unstructured":"Lakshmi P.K.; Kalpana B.; Prasanthi D.; Invasomes-novel vesicular carriers for enhanced skin permeation. Sys Rev Pharm  2013,4(1),26-30","journal-title":"Sys Rev Pharm"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010336809240815050316","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/235472\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010336809240815050316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T11:11:16Z","timestamp":1738235476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/235472\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010336809240815050316","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}